SG

Sapna Gupta

Active Director Director DIN 09268588
DIN 09268588 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Sapna Gupta

Data last updated:

Sapna Gupta is a Director at Parenteral Pharma Private Limited (since 2021). The company operates in Pharma. Parenteral Pharma Private Limited reported revenue of ₹79.7 Lakh (FY 2025).

DIN 09268588
Primary Designation Director
Industry Pharma
First Appointment 05 Aug 2021
Oldest Company Age 22 yrs
Largest company Parenteral Pharma Private Limited · ₹79.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parenteral Pharma Private Limited U24232JK2004PTC002393
Director05 Aug 20212004₹79.7 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Parenteral Pharma Private Limited
Premium access

Shareholding and investment profile for Sapna Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sapna Gupta

Sapna Gupta currently holds 1 directorship: Parenteral Pharma Private Limited (Director, since 05 Aug 2021, revenue ₹79.7 Lakh (FY 2025)).

Sapna Gupta was first appointed on 05 Aug 2021 as Director at Parenteral Pharma Private Limited.

The current boards of Sapna Gupta's companies include Agam Gupta (Parenteral Pharma Private Limited), Jyoti Saroop Gupta (Parenteral Pharma Private Limited), Rozy Gupta (Parenteral Pharma Private Limited), Sahib Gupta (Parenteral Pharma Private Limited), Shanti Saroop Gupta (Parenteral Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available